IPMI China, Hong Kong and Singapore, 2017 – 2025


Focus on three key Far East countries, 2017 to 2025.

This report covers, in great detail, the three main IPMI markets of the region - Hong Kong, China and Singapore. It contains: Market size, Segment size, Profitability, Market players and Shares, Drivers and Future prospects, in over 50 pages of text and charts.

Who should read this report
This report is particularly useful for specialist health insurance and other EB focused brokers and any international health insurers or re-insurers who target the Far East markets. It is also extremely relevant for the various service suppliers and investors who inhabit this space. The report intends to provide the most in-depth, detailed and heavily researched insights for all those making current and future strategic and tactical decisions for this region or globally.
Table of Contents
Table of Contents
Table of Figures
Table of Figures
Pricing & Licensing
The report is delivered via a unique URL immediately on payment. The report is available online only and is neither downloadable nor printable and is restricted to licence holders only.

Three-user Licence £3,000*

Corporate Licence (10 users) £4,500*

To order the report contact the Editor, at

*VAT @ 20% will be added to purchases from the UK Other purchasers will not incur VAT.
FE report cover

Purchase Report

  • How many people will be accessing the publication?
  • This field is for validation purposes and should be left unchanged.

Our manager will contact you to discuss purchase options.